Download Handouts: https://bit.ly/4jkDKwj

We invite you to watch our FREE webinar to discover how the well-known antiparasitics, mebendazole and ivermectin, are being researched as potential options in cancer therapy.
 
What you’ll gain by attending:
• Expert insights into the mechanisms of action behind mebendazole and ivermectin’s anticancer potential
• Review of preclinical and clinical research on its potential use.
• Exploration of therapeutic applications in cancer treatment and ongoing research
• Discussion of regulatory, safety and marketing challenges for both mebendazole and ivermectin as adjunctive cancer therapies
Speakers
• PCCA Clinical Compounding Pharmacist Catherine Henderson, PharmD, BCSCP
• PCCA Vice President of Clinical Services Matt Martin, PharmD, BCSCP
Don’t miss the chance to expand your knowledge and gain insights that could shape future treatment protocols.